Search results
An Ozempic alternative helps people lose weight without as many side effects, study says
Quartz· 1 day agoZealand Pharma surged 23% after it announced positive clinical trial results for its experimental...
New drug's potentially fatal side effects obscured by 'soothing acronym,' doctors say
Los Angeles Times· 6 days agoSeventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical...
Zealand Pharma shares surge after positive results of weight-loss drug that could contend with...
Market Watch· 2 days agoIts Phase 1B study showed that patients...an alternative to incretin-based therapies for the...
Gilead Flashes A Bullish Sign After HIV Drug Proves 100% Effective
Investor's Business Daily· 2 days agoBut these are both daily pills. Experimental drug lenacapavir is an under-the-skin shot twice a...
Obesity drug from Zealand shows potential in early trial
BioPharma Dive via Yahoo Finance· 2 days agoInterim study data suggest the Danish drugmaker can remain in the race to develop new kinds of...
Young’s Medical Matters, What You May Have Missed
KAMR Amarillo· 2 days agoAMARILLO, Texas (KAMR/KCIT) —Medical news comes out daily it seems, and sometimes we can’t look through all of the great things happening in medicine....
Artificial intelligence enables huge Parkinson's disease breakthrough
Daily Express· 5 days agoScientists developed a new test for Parkinson's using artificial intelligence (AI). The study of the...
Zealand Pharma Shares Jump 17% After Positive Trial Results For Ozempic Competitor
Forbes· 2 days agoShares for Zealand Pharma rose by over 17% on Friday, after the Danish biotech firm announced positive trial results for petrelintide, a new weight loss drug the company said ...
Gateway - Quartz
Quartz· 4 days ago“The interim phase 2 analysis for this study is complete, and we are very encouraged with results that...analysis, I would say, we’re confident in MariTide’s differentiated profile and believe ...
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
CNBC· 2 days agoGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial,...
